Floatz logo

Palifermin

Myelofibrosis

Center for International Blood and Marrow Transplant Researchprotein_peptidePhase 2Active
CCC
51/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
73/ 100

Competitive context

47 Active assets in the Myelofibrosis cohort.

Asset / SponsorPhaseRating
Busulphan
City of Hope Medical Center
Phase 2B
CYCLOSPORIN A
City of Hope Medical Center
Phase 2B
Cyclophosphamide
City of Hope Medical Center
Phase 3B
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
University of Arizona
Phase 2/3B
Anti-Thymoglobulin, Rabbit
Fred Hutchinson Cancer Center
Phase 2/3B

View all 50 →

Same molecule, other indications

Palifermin is also rated in:

mucositisDormant
BB
Indicative ·
64 / 100
View asset →
non-Hodgkin lymphomaDormant
B
Indicative ·
63 / 100
View asset →
plasma cell myelomaDormant
B
Indicative ·
61 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →